Hospital-acquired pneumonias (HAPs), including ventilatorassociated pneumonia (VAP), often start in the oral cavity. 1, 2 Bacteria, including dental plaque, can colonize in the oropharyngeal area, 3 and these pathogens can be aspirated into the lungs, causing infection. 4 VAP is the most common infectious complication among ICU patients and accounts for over 47% of all infections. 5 Non-vent patients with conditions including dysphagia, stroke, COPD and malignancy are also at risk for HAP. 6,7
THE IMPORTANCE OF ORAL CARE IN ADDRESSING HAP AND VAP RISK FACTORS
More and more bacteria adhere, and existing bacteria begin to multiply forming a microcolony.
Bacteria spread in all directions becoming a macrocolony; bacteria begin to grow in multiple layers.
Bacteria macrocolonies spread and overlap, resulting in full biofilm.
Bacteria beginning to form. 
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BIOFILM FORMING OVER A 24-HOUR PERIOD IMPROVING SURVEILLANCE FOR VENTILATOR-ASSOCIATED EVENTS IN ADULTS
The Centers for Disease Control and Prevention (CDC) has proposed a change to the way VAP surveillance is reported through the National Healthcare Safety Network (NHSN). Under the proposal, hospitals would be required to publicly report VAPs, Ventilator-Associated Conditions (VACs) and Infections with Ventilator-Associated Conditions (IVACs). Biofilms are a thin, usually resistant layer of microorganisms (as bacteria) that form on and coat various surfaces. 1 Biofilms have been found to be involved in up to 80% of infections. 2 Dental plaque is one of the most common biofilms and is responsible for various periodontal diseases, including gingivitis. 3
BIOFILMS: A RISK FACTOR FOR PNEUMONIA VAP CONSEQUENCES
n Mortality rate of up to 76%. 4 n Mean hospitalization costs were $99,598 for patients with VAP and $59,770 for patients without VAP (P <.0001), resulting in an absolute difference of $39,828. 5 n Mean length of stay can reach 23 days. 6 n 9.6 additional days on the vent, 6.1 extra days in the ICU and 11.5 more days in the hospital. 7
In addition to increased infection risk, the biofilm grows thicker and calcifies in the alveolus, rendering gases exchange ineffective. Subsequently, under mechanical ventilation, the biofilm can potentially attach and accumulate in the endotrach lumen, increasing airway resistance and Work of Breathing (WOB). 9
COSTS IN A MATCHED COHORT OF 2,144 PATIENTS WITH VENTILATOR-ASSOCIATED PNEUMONIA (VAP) AND 2,144 PATIENTS WITHOUT VAP 5
Toothette ® Oral Care addresses key VAP risk factors with a comprehensive approach based on cleaning, debriding, suctioning and moisturizing the entire oral cavity. The Toothette brand incorporates 24-hour systems, innovative tools and effective solutions, all while facilitating compliance to your oral care protocol. 88% of the oral care market is trusted to Toothette brand oral care. 
BEATING BIOFILMS
"If oral care is not started upon admission, the mouth could become colonized with harmful bacteria within the first 48 hours. Plaque on the teeth can provide a breeding ground for this growth of bacteria…The most effective way to remove plaque is to use a brush." 2
CLEAN
Brushing and suctioning with an antiseptic agent kills 3 and mechanically removes bacterial biofilms (dental plaque) from teeth and oral tissues.
DEBRIDE
Swabbing and suctioning with Perox-A-Mint ® solution helps remove dead, loosened biofilms. 4
MOISTURIZE
Water-based formula soothes and moisturizes oral tissues.
BEATING BIOFILMS WITH COMPREHENSIVE ORAL CARE
88%
of the oral care market is trusted to the Q•Care and Toothette brands. 1 a l l o t h e r b r a n d s 
COVERED YANKAUER
Helps remove debris and secretions.
n Soft tip gentle on fragile oral tissues. n User-friendly, one-piece design.
Chlorhexidine Gluconate 0.12% Oral Rinse n Indicated for the treatment of gingivitis, as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing. n Single dose bottle is ready to use -no product waste due to measuring and mixing. n Provides antimicrobial activity during oral rinsing. n Prescription grade requires documentation on MAR and promotes better oral care compliance.
Perox-A-Mint ® Solution n Mechanically cleans and debrides with 1.5% hydrogen peroxide.
Antiseptic Oral Rinse
n Helps reduce chance of infection in minor oral irritation with 0.05% cetylpyridinium chloride (CPC). n Promotes healing by reducing bacteria known to cause most oral dysfunction. 9, 10 Antiplaque Solution n Helps remove and prevent plaque that leads to gingivitis with 0.05% cetylpyridinium chloride. n Alcohol-free and non-irritating, with pleasant mint flavor.
Alcohol-Free Mouthwash
n Cleans and refreshes oral cavity with pleasant mint flavor.
Mouth Moisturizer
n Soothes and moisturizes with Vitamin E and coconut oil. n Water-based formula can be used inside mouth. 
OROPHARYNGEAL SUCTION CATHETER
2010
New smaller, more maneuverable suction toothbrush with 30x more contact points than representative competitor's molded plastic bristle toothbrush.
The Space-saving Bedside Bracket helps increase compliance to protocol.
Suction handle provides variable suction control and allows quick tool changes.
Thumb port provides easy suction control.
Take a comprehensive approach to oral hygiene and facilitate compliance to your protocol with Q•Care Oral Cleansing and Suctioning Systems.
SYSTEMS INCLUDE:
n Easy to use, sequential q2˚, q4˚ or q8° packaging to lay out each step.
n Minimal setup-less time opening packaging and more time for oral care.
n Superior components and cleansing solutions.
n Simple tools work with your existing suction equipment.
n No mixing, no mess burstable solution packets.
n Oral Check ™ barcode on systems that contain over-the-counter drug solutions. Allows scanning of each product package for documentation on the MAR, further enhancing protocol compliance. n Prescription drug requires documentation on the MAR, helping to increase compliance to oral care protocol.
Q•Care with Thumb Port Tools
n Tools connect directly to suction lines.
n Thumb port on Suction Swab, Suction Toothbrush and Suction Catheter allows staff to easily control suction.
n Covered Yankauer provides variable suction control with on/off switch.
Q•Care with Suction Handle
n Interchangeable tools connect to Suction Handle. ON/OFF switch provides variable suction control. WHAT TO EXPECT WHEN USING CHLORHEXIDINE GLUCONATE ORAL RINSE Your dentist has prescribed Chlorhexidine Gluconate Oral Rinse to treat your gingivitis, to help reduce the redness, and swelling of your gums, and also to help you control any gum bleeding. Use Chlorhexidine Gluconate Oral Rinse regularly, as directed by your dentist, in addition to daily brushing. Spit out after use. Chlorhexidine Gluconate Oral Rinse should not be swallowed.
Q•CARE WITH SUCTION HANDLE LENGTH OF STAY (LOS) YANKAUER HOLDER
If you develop allergic symptoms such as skin rash, itch, generalized swelling, breathing difficulties, light headedness, rapid heart rate, upset stomach or diarrhea, seek medical attention immediately. Chlorhexidine Gluconate Oral Rinse should not be used by persons who have a sensitivity to it or its components.
Chlorhexidine Gluconate Oral Rinse may cause some tooth discoloration, or increase in tartar (calculus) formation, particularly in areas where stain and tartar usually form. It is important to see your dentist for removal of any stain or tartar at least every six months or more frequently if your dentist advises.
• Both stain and tartar can be removed by your dentist or hygienist. Chlorhexidine Gluconate Oral Rinse may cause permanent discoloration of some front-tooth fillings.
• To minimize discoloration, you should brush and floss daily, emphasizing areas which begin to discolor.
• Chlorhexidine Gluconate Oral Rinse may taste bitter to some patients and can affect how foods and beverages taste. This will become less noticeable in most cases with continued use of Chlorhexidine Gluconate Oral Rinse.
• To avoid taste interference, rinse with Chlorhexidine Gluconate Oral Rinse after meals. Do not rinse with water or other mouthwashes immediately after rinsing with Chlorhexidine Gluconate Oral Rinse.
If you have any questions or comments about Chlorhexidine Gluconate Oral Rinse, contact your dentist or pharmacist.
Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Additional time may be required to complete the prophylaxis. Discretion should be used when prescribing to patients with anterior facial restorations with rough surfaces or margins. If natural stain cannot be removed from these surfaces by a dental prophylaxis, patients should be excluded from Chlorhexidine Gluconate Oral Rinse treatment if permanent discoloration is unacceptable. Stain in these areas may be difficult to remove by dental prophylaxis and on rare occasions may necessitate replacement of these restorations.
3. Some patients may experience an alteration in taste perception while undergoing treatment with Chlorhexidine Gluconate Oral Rinse. Rare instances of permanent taste alteration following Chlorhexidine Gluconate Oral Rinse use have been reported via post-marketing product surveillance.
PREGNANCY: TERATOGENIC EFFECTS Pregnancy Category B. Reproduction Studies have been performed in rats and rabbits at chlorhexidine gluconate doses up to 300 mg/kg/day and 40 mg/kg/day respectively, and have not revealed evidence of harm to fetus. However, adequate and well-controlled studies in pregnant women have not been done. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.
NURSING MOTHERS: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Chlorhexidine Gluconate Oral Rinse is administered to nursing women. In parturition and lactation studies with rats, no evidence of impaired parturition or of toxic effects to suckling pups was observed when chlorhexidine gluconate was administered to dams at doses that were over 100 times greater than that which would result from a person's ingesting 30 mL of Chlorhexidine Gluconate Oral Rinse per day.
PEDIATRIC USE: Clinical effectiveness and safety of Chlorhexidine Gluconate Oral Rinse have not been established in children under the age of 18.
CARCINOGENESIS, MUTAGENESIS, AND IMPAIRMENT OF FERTILITY:
In a drinking water study in rats, carcinogenic effects were not observed at doses up to 38 mg/kg/day. Mutagenic effects were not observed in two mammalian in vivo mutagenesis studies with chlorhexidine gluconate. The highest doses of chlorhexidine used in a mouse dominant-lethal assay and a hamster cytogenetics test were 1000 mg/ kg/day and 250 mg/kg/day, respectively. No evidence of impaired fertility was observed in rats at doses up to 100 mg/kg/day.
ADVERSE REACTIONS:
The most common side effects associated with chlorhexidine gluconate oral rinses are: 1) an increase in staining of teeth and other oral surfaces; 2) an increase in calculus formation; and 3) an alteration in taste perception; see WARNINGS and PRECAUTIONS. Oral irritation and local allergy-type symptoms have been spontaneously reported as side effects associated with use of chlorhexidine gluconate rinse. The following oral mucosal side effects were reported during placebo-controlled adult clinical trials: aphthous ulcer, grossly obvious gingivitis, trauma, ulceration, erythema, desquamation, coated tongue, keratinization, geographic tongue, mucocele, and short frenum. Each occurred at a frequency of less than 1.0%. Among post marketing reports, the most frequently reported oral mucosal symptoms associated with Chlorhexidine Gluconate Oral Rinse are stomatitis, gingivitis, glossitis, ulcer, dry mouth, hypesthesia, glossal edema, and paresthesia. Minor irritation and superficial desquamation of the oral mucosa have been noted in patients using Chlorhexidine Gluconate Oral Rinse. There have been cases of parotid gland swelling and inflammation of the salivary glands (sialadenitis) reported in patients using Chlorhexidine Gluconate Oral Rinse. Use of Chlorhexidine Gluconate Oral Rinse in a six month clinical study did not result in any significant changes in bacterial resistance, overgrowth of potentially opportunistic organisms or other adverse changes in the oral microbial ecosystem. Three months after Chlorhexidine Gluconate Oral Rinse was discontinued, the number of bacteria in plaque had returned to baseline levels and resistance of plaque bacteria to chlorhexidine gluconate was equal to that at baseline.
PHARMACOKINETICS:
Pharmacokinetic studies with Chlorhexidine Gluconate Oral Rinse indicate approximately 30% of the active ingredient, chlorhexidine gluconate, is retained in the oral cavity following rinsing. This retained drug is slowly released in the oral fluids. Studies conducted on human subjects and animals demonstrate chlorhexidine gluconate is poorly absorbed from the gastrointestinal tract. The mean plasma level of chlorhexidine gluconate reached a peak of 0.206 μg/g in humans 30 minutes after they ingested a 300 mg dose of the drug. Detectable levels of chlorhexidine gluconate were not present in the plasma of these subjects 12 hours after the compound was administered. Excretion of chlorhexidine gluconate occurred primarily through the feces (~90%). Less than 1% of the chlorhexidine gluconate ingested by these subjects was excreted in the urine.
INDICATION AND USAGE:
Chlorhexidine Gluconate Oral Rinse is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing. Chlorhexidine Gluconate Oral Rinse has not been tested among patients with acute necrotizing ulcerative gingivitis (ANUG). For patients having coexisting gingivitis and periodontitis, see PRECAUTIONS.
CONTRAINDICATIONS: Chlorhexidine Gluconate Oral Rinse should not be used by persons who are known to be hypersensitive to chlorhexidine gluconate or other formula ingredients.
WARNINGS:
The effect of Chlorhexidine Gluconate Oral Rinse on periodontitis has not been determined. An increase in supragingival calculus was noted in clinical testing in Chlorhexidine Gluconate Oral Rinse users compared with control users. It is not known if Chlorhexidine Gluconate Oral Rinse use results in an increase in subgingival calculus. Calculus deposits should be removed by a dental prophylaxis at intervals not greater than six months. Anaphylaxis, as well as serious allergic reactions, have been reported during postmarketing use with dental products containing chlorhexidine, see CONTRAINDICATIONS.
PRECAUTIONS: GENERAL:
1. For patients having coexisting gingivitis and periodontitis, the presence or absence of gingival inflammation following treatment with Chlorhexidine Gluconate Oral Rinse should not be used as a major indicator of underlying periodontitis. CustomerOne is a unique program offered by Sage to reinforce your decision to bring our products into your facility. It tracks performance and compliance, and demonstrates improvement in outcomes.
CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE
Sage provides customized measurement and analysis, and then compiles your results into valuable, actionable reports that can be shared with other decision-makers in your facility. CustomerOne is all about your needs and expectations. If there's anything you need to measure, we can help.
LET US HELP YOU VALIDATE YOUR SUCCESS!
Call your Sage Sales Representative to learn more about CustomerOne.
800-323-2220
SAGE PROVIDES UNMATCHED RESOURCES INCLUDING:
Customizable protocols n Ready to use or customizable to meet your unit's unique needs.
Education and training
n Presentation about the importance of clinical oral care in preventing HAP/VAP.
n Personalized inservicing for all shifts.
n Online training videos, presentations, educational posters, instructions and more.
Implementation plan n
Step-by-step checklists for easy transition.
n Includes clinical practice assessment, staff education, product evaluation, inservice conversion, protocol utilization tool, etc.
Performance improvement plan (PIP)
n Track the impact of routine oral care and closed end suction on VAP rates.
n Easy-to-use template makes it simple to document objectives, protocol, clinical evaluation and results.
Cost Justification Tool
This unique tool is designed to help compare your projected annual oral hygiene product expenses using Toothette ® Oral Care to estimated VAP treatment costs.
Once the break-even costs are calculated, you will see the financial savings for each additional VAP/HAP that is avoided.
To see the positive financial impact Toothette Oral Care can have in your facility, visit: www.sageproducts.com/education/costJustStart.cfm
